Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

Euro labs boost Sonic Healthcare's profit

Christian Edwards  |  15 Feb 2018Text size  Decrease  Increase  |  
Email to Friend

Page 1 of 1

SYDNEY - [AAP] Sonic Healthcare's (ASX: SHL) first-half profit has grown 16 per cent to $228.6 million as the pathology and radiology services group achieved revenue growth in each of its global operations.

Sonic's Australian laboratory business, its largest, generated revenue growth of five per cent in the six months to December as it continued to recover from regulatory changes to GP bulk billing on pathology and imaging services.

Revenue growth was strongest in Europe, up 12.6 per cent, as the company won an exclusive contract to provide lab services to two London hospitals, and completed the acquisition of two lab groups in Germany.

Chief executive Colin Goldschmidt said the company's US business improved its margins despite the impact of hurricanes Irma and Harvey in the half year.

"Achieving a 20 basis point margin improvement in these circumstances is an outstanding result," Dr Goldschmidt said.

Sonic's half year profit also got a $20 million boost from the revaluation of deferred tax liabilities following changes to US tax rates.

The company's first-half pre-tax earnings were up nine per cent from a year earlier, and Sonic said it is on track to achieve its forecast annual pre-tax earnings growth of between six and eight per cent.

Email to Friend
Market News and Views Sign up today and receive our free Morning Note e-newsletter, daily in your inbox.

Sonic shares were down 72 cents, or three per cent, at $23.48 at 1220 AEDT.

SONIC HEALTHCARE DELIVERS PROFIT GROWTH:

* Half year net profit up 12.6pc to $228.6m

* Revenue up 7.9pc to $2.67bn

* Partially franked interim dividend up 1 cent to 32 cents

 

AAP logo image

© [2018] Australian Associated Press Pty Limited (AAP) or its Licensors. This is the Morningstar service with content provided by AAP where indicated. AAP reserves all rights, including copyright, in services provided by it. The information in the service is for personal use only, does not constitute financial product advice (whether general or personal) and may not be re-written, copied, re-sold or re-distributed, framed, linked or otherwise used whether for compensation of any kind or not, without the prior written permission of AAP. You should seek advice from a professional financial adviser before making decision to acquire or dispose of a financial product.

This service is published for general information purposes only without assuming a duty of care. AAP is not in the business of providing financial product advice (whether personal or general advice), and gives no warranty, guarantee or other representation about the accuracy of the information or images contained in this service. AAP is not liable for errors, omissions in, delays or interruptions to or cessation of the services through negligence or otherwise. The globe symbol and "AAP" are registered trademarks.

Email To Friend